To evaluate the importance of the raised levels of growth hormone that characterize poor diabetic control, we gave growth hormone for 21 to 45 hours in the form of hourly 100-micrograms pulses to 14 diabetics being treated by insulin pump. Insulin-pump settings and meals were kept constant. Mean 24-hour levels of growth hormone (+/- S.E.M.) rose from 8 +/- 1 to 16 +/- 2 ng per milliliter--values identical to those observed in 12 other patients with poorly controlled diabetes (17 +/- 3 ng per milliliter). Plasma glucose concentrations doubled within 8 to 10 hours and remained elevated until growth hormone was discontinued (fasting glucose level rose from 86 +/- 11 to 204 +/- 17 mg per deciliter at 18 hours and to 240 +/- 20 mg per deciliter at 42 hours). The hyperglycemia was due mainly to a marked stimulation of hepatic glucose production that occurred without changes in levels of free insulin or glucagon. Levels of circulating free fatty acids, ketones, and branched-chain amino acids were also increased. The moderate elevations in growth hormone levels that occur in poorly controlled diabetes can themselves reproduce the whole spectrum of abnormal metabolic fuel concentrations that are associated with poor diabetic control, despite optimized insulin treatment. Thus, hypersecretion of growth hormone may be the cause as much as the consequence of poor diabetic control.
This article has been cited by other articles:
Saukkonen, T., Shojaee-Moradie, F., Williams, R. M., Amin, R., Yuen, K. C., Watts, A., Acerini, C. L., Umpleby, A. M., Dunger, D. B.
(2006). Effects of Recombinant Human IGF-I/IGF-Binding Protein-3 Complex on Glucose and Glycerol Metabolism in Type 1 Diabetes.. Diabetes
55: 2365-2370
[Abstract][Full Text]
Guelfi, K. J., Jones, T. W., Fournier, P. A.
(2005). Intermittent High-Intensity Exercise Does Not Increase the Risk of Early Postexercise Hypoglycemia in Individuals With Type 1 Diabetes. Diabetes Care
28: 416-418
[Full Text]
Saukkonen, T., Amin, R., Williams, R. M., Fox, C., Yuen, K. C., White, M. A., Umpleby, A. M., Acerini, C. L., Dunger, D. B.
(2004). Dose-Dependent Effects of Recombinant Human Insulin-Like Growth Factor (IGF)-I/IGF Binding Protein-3 Complex on Overnight Growth Hormone Secretion and Insulin Sensitivity in Type 1 Diabetes. J. Clin. Endocrinol. Metab.
89: 4634-4641
[Abstract][Full Text]
Landau, D., Israel, E., Rivkis, I., Kachko, L., Schrijvers, B. F., Flyvbjerg, A., Phillip, M., Segev, Y.
(2003). The effect of growth hormone on the development of diabetic kidney disease in rats. Nephrol Dial Transplant
18: 694-702
[Abstract][Full Text]
Turner, B. C., Jenkins, E., Kerr, D., Sherwin, R. S., Cavan, D. A.
(2001). The Effect of Evening Alcohol Consumption on Next-Morning Glucose Control in Type 1 Diabetes. Diabetes Care
24: 1888-1893
[Abstract][Full Text]
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., Wall, B. M.
(2001). Management of Hyperglycemic Crises in Patients With Diabetes. Diabetes Care
24: 131-153
[Full Text]
Pearce, I A, Ilango, B, Sells, R A, Wong, D
(2000). Stabilisation of diabetic retinopathy following simultaneous pancreas and kidney transplant. Br. J. Ophthalmol.
84: 736-740
[Abstract][Full Text]
Botker, H. E., Wiggers, H., Bottcher, M., Christiansen, J. S., Nielsen, T. T., Gjedde, A., Schmitz, O.
(2000). Short-term effects of growth hormone on myocardial glucose uptake in healthy humans. Am. J. Physiol. Endocrinol. Metab.
278: E1053-E1059
[Abstract][Full Text]
Catalina, P. F., Mallo, F., Andrade, M. A., García-Mayor, R. V., Diéguez, C.
(1998). Growth Hormone (GH) Response to GH-Releasing Peptide-6 in Type 1 Diabetic Patients with Exaggerated GH-Releasing Hormone-Stimulated GH Secretion. J. Clin. Endocrinol. Metab.
83: 3663-3667
[Abstract][Full Text]
Vahl, N., Moller, N., Lauritzen, T., Christiansen, J. S., Jorgensen, J. O. L.
(1997). Metabolic Effects and Pharmacokinetics of a Growth Hormone Pulse in Healthy Adults: Relation to Age, Sex, and Body Composition. J. Clin. Endocrinol. Metab.
82: 3612-3618
[Abstract][Full Text]
Van Cauter, E., Polonsky, K. S., Scheen, A. J.
(1997). Roles of Circadian Rhythmicity and Sleep in Human Glucose Regulation. Endocr. Rev.
18: 716-738
[Abstract][Full Text]
Previous
